Zhaoke Ophthalmology Limited (HKG:6622)
Hong Kong · Delayed Price · Currency is HKD 3.000
+0.100 (3.45%)
May 7, 2026, 4:08 PM HKT
Zhaoke Ophthalmology Market Cap
Zhaoke Ophthalmology has a market cap or net worth of 1.65 billion as of May 7, 2026. Its market cap has increased by 106.46% in one year.
Market Cap
1.65B
Enterprise Value
902.38M
Revenue
35.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.00
Market Cap Chart
Since April 29, 2021, Zhaoke Ophthalmology's market cap has decreased from 7.66B to 1.65B, a decrease of -78.52%. That is a compound annual growth rate of -26.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 6, 2026 | 1.59B | -1.89% |
| Dec 31, 2025 | 1.62B | 147.49% |
| Dec 31, 2024 | 655.37M | -69.49% |
| Dec 29, 2023 | 2.15B | 30.79% |
| Dec 30, 2022 | 1.64B | -46.83% |
| Dec 31, 2021 | 3.09B | -59.69% |
| Apr 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 2.57B |
| SinoMab BioScience | 2.01B |
| Frontage Holdings | 1.99B |
| ImmuneOnco Biopharmaceuticals (Shanghai) | 1.91B |
| Mabpharm | 1.86B |
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1.73B |
| Beijing Biostar Pharmaceuticals | 1.71B |
| Cutia Therapeutics | 1.67B |